Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 4/2011

Open Access 01-08-2011 | Original Article

Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control

Authors: Leo M. J. de Sonneville, Stephan C. J. Huijbregts, Robert Licht, Joseph A. Sergeant, Francjan J. van Spronsen

Published in: Journal of Inherited Metabolic Disease | Issue 4/2011

Login to get access

Abstract

Sixty-four children, aged 7 to 14 years, with early-treated PKU, were compared with control children on visual evoked potential (VEP) amplitudes and latencies and auditory mismatch negativity (MMN) amplitudes. It was further investigated whether indices of dietary control would be associated with these evoked potentials parameters. There were no significant differences between controls and children with PKU in VEP- and MMN-indices. However, higher lifetime Phe levels were, in varying degree and stronger than concurrent Phe level, related to increased N75 amplitudes, suggesting abnormalities in attention, and longer P110 latencies, indicating a reduction in speed of neural processing, possibly due to deficits in myelination or reduced dopamine levels in brain and retina. Similarly, higher lifetime Phe levels and Index of Dietary Control (IDC) were associated with decreased MMN amplitudes, suggesting a reduced ability to respond to stimulus change and poorer triggering of the frontally mediated attention switch. In summary, the present study in children with PKU investigated bottom-up information processing, i.e., triggered by external events, a fundamental prerequisite for the individual’s responsiveness to the outside world. Results provide evidence that quality of dietary control may affect the optimal development of these pre-attentive processes, and suggest the existence of windows of vulnerability to Phe exposure.
Literature
go back to reference Agostoni C, Harvie A, McCulloch DL, Demellweek C, Cockburn F, Giovannini M, Murray G, Harkness RA (2006) A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol 48:207–212PubMedCrossRef Agostoni C, Harvie A, McCulloch DL, Demellweek C, Cockburn F, Giovannini M, Murray G, Harkness RA (2006) A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol 48:207–212PubMedCrossRef
go back to reference Albrecht J, Garbade SF, Burgard P (2008) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414–421PubMedCrossRef Albrecht J, Garbade SF, Burgard P (2008) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414–421PubMedCrossRef
go back to reference Anderson PJ, Wood SJ, Francis DE, Coleman L, Warwick L, Casanelia S, Anderson VA, Boneh A (2004) Neuropsychological functioning in children with early-treated phenylketonuria: Impact of white matter abnormalities. Dev Med Child Neurol 46:230–238PubMedCrossRef Anderson PJ, Wood SJ, Francis DE, Coleman L, Warwick L, Casanelia S, Anderson VA, Boneh A (2004) Neuropsychological functioning in children with early-treated phenylketonuria: Impact of white matter abnormalities. Dev Med Child Neurol 46:230–238PubMedCrossRef
go back to reference Ashtari M, Cervellione KL, Hasan KM, Wu J, McIlree C, Kester H et al. (2007) White matter development during late adolescence in healthy males: a cross-sectional diffusion tensor imaging study. Neuroimage 35:501–510PubMedCrossRef Ashtari M, Cervellione KL, Hasan KM, Wu J, McIlree C, Kester H et al. (2007) White matter development during late adolescence in healthy males: a cross-sectional diffusion tensor imaging study. Neuroimage 35:501–510PubMedCrossRef
go back to reference Azadi B, Seddigh A, Tehrani-Doost M, Alaghband-Rad J, Ashrafi MR (2009) Executive dysfunction in treated phenylketonuric patients. Eur Child Adolesc Psychiatry 18:360–368PubMedCrossRef Azadi B, Seddigh A, Tehrani-Doost M, Alaghband-Rad J, Ashrafi MR (2009) Executive dysfunction in treated phenylketonuric patients. Eur Child Adolesc Psychiatry 18:360–368PubMedCrossRef
go back to reference Beblo S, Reinhardt A, Muntau AC, Mueller-Felber W, Roscher A, Koletzko B (2001) Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 57:1488–1491PubMed Beblo S, Reinhardt A, Muntau AC, Mueller-Felber W, Roscher A, Koletzko B (2001) Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology 57:1488–1491PubMed
go back to reference Beringer J (1996) Experimental Run Time Systems. BeriSoft Cooperation, Frankfurt an Main, Germany Beringer J (1996) Experimental Run Time Systems. BeriSoft Cooperation, Frankfurt an Main, Germany
go back to reference Bickel H, Gerrard J, Hickmans EM (1953) Influence of phenylalanine intake on phenylketonuria. Lancet 265:812–813PubMedCrossRef Bickel H, Gerrard J, Hickmans EM (1953) Influence of phenylalanine intake on phenylketonuria. Lancet 265:812–813PubMedCrossRef
go back to reference Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74–S79PubMedCrossRef Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74–S79PubMedCrossRef
go back to reference Cardona F, Leuzzi V, Antonozi I, Benedetti P, Loizzo A (1991) The development of auditory and visual evoked potentials in early treated phenylketonuric children. EEG Clin Neurophysiol 80:8–15 Cardona F, Leuzzi V, Antonozi I, Benedetti P, Loizzo A (1991) The development of auditory and visual evoked potentials in early treated phenylketonuric children. EEG Clin Neurophysiol 80:8–15
go back to reference Channon S, German E, Cassina C, Lee P (2004) Executive functioning, memory and learning in phenylketonuria. Neuropsychology 18:613–620PubMedCrossRef Channon S, German E, Cassina C, Lee P (2004) Executive functioning, memory and learning in phenylketonuria. Neuropsychology 18:613–620PubMedCrossRef
go back to reference Channon S, Mockler C, Lee P (2005) Executive functioning and speed of processing in phenylketonuria. Neuropsychology 18:679–686CrossRef Channon S, Mockler C, Lee P (2005) Executive functioning and speed of processing in phenylketonuria. Neuropsychology 18:679–686CrossRef
go back to reference Christ SE, Huijbregts SCJ, De Sonneville LMJ, White DA (2010) Executive Function in Early-Treated Phenylketonuria: Profile and Underlying Mechanisms. Mol Genet Metab 99:S22–S32PubMedCrossRef Christ SE, Huijbregts SCJ, De Sonneville LMJ, White DA (2010) Executive Function in Early-Treated Phenylketonuria: Profile and Underlying Mechanisms. Mol Genet Metab 99:S22–S32PubMedCrossRef
go back to reference Cleary MA, Walter JH, Jenkins JP, Alani SM, Tyler K, Whittle D (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344:87–90PubMedCrossRef Cleary MA, Walter JH, Jenkins JP, Alani SM, Tyler K, Whittle D (1994) Magnetic resonance imaging of the brain in phenylketonuria. Lancet 344:87–90PubMedCrossRef
go back to reference Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJ Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, Hillsdale, NJ
go back to reference Coskun T, Topcu M, Ustundag I, Ozlap I, Renda Y, Cyger A, Nurlu G (1993) Neurophysiological studies of patients with classical phenylketonuria: Evaluation of results of IQ scores, EEG and evoked potentials. Turk J Pediatr 35:1–10PubMed Coskun T, Topcu M, Ustundag I, Ozlap I, Renda Y, Cyger A, Nurlu G (1993) Neurophysiological studies of patients with classical phenylketonuria: Evaluation of results of IQ scores, EEG and evoked potentials. Turk J Pediatr 35:1–10PubMed
go back to reference Creel D, Buehler BA (1982) Pattern evoked potentials in phenylketonuria. EEG Clin Neurophysiol 53:220–223CrossRef Creel D, Buehler BA (1982) Pattern evoked potentials in phenylketonuria. EEG Clin Neurophysiol 53:220–223CrossRef
go back to reference DeRoche K, Welsh M (2008) Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function. Dev Neuropsychol 33:474–504PubMedCrossRef DeRoche K, Welsh M (2008) Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function. Dev Neuropsychol 33:474–504PubMedCrossRef
go back to reference Di Russo F, Pitzalis S, Spitoni G, Aprile T, Patria F, Spinelli D, Hillyard SA (2005) Identification of the neural sources of the pattern-reversal VEP. Neuroimage 24:874–886PubMedCrossRef Di Russo F, Pitzalis S, Spitoni G, Aprile T, Patria F, Spinelli D, Hillyard SA (2005) Identification of the neural sources of the pattern-reversal VEP. Neuroimage 24:874–886PubMedCrossRef
go back to reference Diamond A (2001) A model system for studying the role of dopamine in the prefrontal cortex during esrly development in humans: Early and continuously treated phenylketonuria. In: Nelson CA, Luciana M (eds) Handbook of developmental cognitive neuroscience. Massachusetts, MIT Press, Cambridge Diamond A (2001) A model system for studying the role of dopamine in the prefrontal cortex during esrly development in humans: Early and continuously treated phenylketonuria. In: Nelson CA, Luciana M (eds) Handbook of developmental cognitive neuroscience. Massachusetts, MIT Press, Cambridge
go back to reference Diamond A, Herzberg C (1996) Impaired sensitivity to visual contrast in children treated early and continuously for phenylketonuria. Brain 119:523–538PubMedCrossRef Diamond A, Herzberg C (1996) Impaired sensitivity to visual contrast in children treated early and continuously for phenylketonuria. Brain 119:523–538PubMedCrossRef
go back to reference Diamond A, Prevor MB, Callender G, Druin DP (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monographs Soc Res Child Develop 62 (4, Serial No. 252) Diamond A, Prevor MB, Callender G, Druin DP (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monographs Soc Res Child Develop 62 (4, Serial No. 252)
go back to reference Ding XQ, Fiehler J, Kohlschutter B, Wittkugel O, Grzyska U, Zeumer H, Ullrich K (2008) MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients. J Magn Reson Imaging 27:998–1004PubMedCrossRef Ding XQ, Fiehler J, Kohlschutter B, Wittkugel O, Grzyska U, Zeumer H, Ullrich K (2008) MRI abnormalities in normal-appearing brain tissue of treated adult PKU patients. J Magn Reson Imaging 27:998–1004PubMedCrossRef
go back to reference Duncan CC, Barry RJ, Conolly JF, Fischer C, Michie PT, Näätänen R, Polich J, Reinvang I, Van Petten C (2009) Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 120:1883–1908PubMedCrossRef Duncan CC, Barry RJ, Conolly JF, Fischer C, Michie PT, Näätänen R, Polich J, Reinvang I, Van Petten C (2009) Event-related potentials in clinical research: guidelines for eliciting, recording, and quantifying mismatch negativity, P300, and N400. Clin Neurophysiol 120:1883–1908PubMedCrossRef
go back to reference Dyer C (1999) Pathophysiology of phenylketonuria. Ment Retard Dev Disabil Res Rev 5:104–112CrossRef Dyer C (1999) Pathophysiology of phenylketonuria. Ment Retard Dev Disabil Res Rev 5:104–112CrossRef
go back to reference Giard MH, Perrin F, Pernier J, Bouchet P (1990) Brain generators implicated in processing of auditory stimulus deviance: a topographic event-related potential study. Psychophysiology 27:627–740PubMedCrossRef Giard MH, Perrin F, Pernier J, Bouchet P (1990) Brain generators implicated in processing of auditory stimulus deviance: a topographic event-related potential study. Psychophysiology 27:627–740PubMedCrossRef
go back to reference Giorgio A, Watkins KE, Douaud G, James AC, James S, De Stefano N et al. (2008) Changes in white matter microstructure during adolescence. Neuroimage 39:52–61PubMedCrossRef Giorgio A, Watkins KE, Douaud G, James AC, James S, De Stefano N et al. (2008) Changes in white matter microstructure during adolescence. Neuroimage 39:52–61PubMedCrossRef
go back to reference Giovannini M, Valsasina R, Villani R, Ducati A, Riva E, Landi A, Longhi R (1988) Pattern reversal visual evoked potentials in phenylketonuria. J Inherit Metab Dis 11:416–421PubMedCrossRef Giovannini M, Valsasina R, Villani R, Ducati A, Riva E, Landi A, Longhi R (1988) Pattern reversal visual evoked potentials in phenylketonuria. J Inherit Metab Dis 11:416–421PubMedCrossRef
go back to reference Henderson RM, McCulloch DL, Herbert AM, Robinson PH, Taylor MJ (2000) Visual event-related potentials in children with phenylketonuria. Acta Paediatr 89:52–57PubMedCrossRef Henderson RM, McCulloch DL, Herbert AM, Robinson PH, Taylor MJ (2000) Visual event-related potentials in children with phenylketonuria. Acta Paediatr 89:52–57PubMedCrossRef
go back to reference Hommes FA, Eller AG, Taylor EH (1982) Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalanaemia. Relevance to the termination of dietary treatment in human phenylketonuria. J Inherit Metab Dis 5:21–27PubMedCrossRef Hommes FA, Eller AG, Taylor EH (1982) Turnover of the fast components of myelin and myelin proteins in experimental hyperphenylalanaemia. Relevance to the termination of dietary treatment in human phenylketonuria. J Inherit Metab Dis 5:21–27PubMedCrossRef
go back to reference Huijbregts SCJ, De Sonneville LMJ, Licht R, Van Spronsen FJ, Verkerk PH, Sergeant JA (2002a) Sustained attention and inhibition of cognitive interference in treated phenylketonuria: Associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 40:7–15PubMedCrossRef Huijbregts SCJ, De Sonneville LMJ, Licht R, Van Spronsen FJ, Verkerk PH, Sergeant JA (2002a) Sustained attention and inhibition of cognitive interference in treated phenylketonuria: Associations with concurrent and lifetime phenylalanine concentrations. Neuropsychologia 40:7–15PubMedCrossRef
go back to reference Huijbregts SCJ, De Sonneville LMJ, Van Spronsen FJ, Licht R, Sergeant JA (2002b) The neuropsychological profile of early and continuously treated phenylketonuria: Orienting, vigilance, and maintenance versus manipulation-functions of working memory. Neurosci Biobehav Rev 26:697–712PubMedCrossRef Huijbregts SCJ, De Sonneville LMJ, Van Spronsen FJ, Licht R, Sergeant JA (2002b) The neuropsychological profile of early and continuously treated phenylketonuria: Orienting, vigilance, and maintenance versus manipulation-functions of working memory. Neurosci Biobehav Rev 26:697–712PubMedCrossRef
go back to reference Jones SJ, Turano G, Kriss A, Shawkat F, Kendall B, Thompson AJ (1995) Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ. J Neurol Neurosurg Psychiatry 59:260–265CrossRef Jones SJ, Turano G, Kriss A, Shawkat F, Kendall B, Thompson AJ (1995) Visual evoked potentials in phenylketonuria: association with brain MRI, dietary state, and IQ. J Neurol Neurosurg Psychiatry 59:260–265CrossRef
go back to reference Kolb B, Fantie B (1997) Development of the child’s brain and behavior. In: Reynolds CR, Fletcher-Janzen E (eds) Handbook of clinical child neuropsychology. Plenum, New York, pp 17–41 Kolb B, Fantie B (1997) Development of the child’s brain and behavior. In: Reynolds CR, Fletcher-Janzen E (eds) Handbook of clinical child neuropsychology. Plenum, New York, pp 17–41
go back to reference Koletzko B, Beblo S, Demmelmair H, Müller-Felber W, Hanebutt FL (2009) Does dietary DHA improve neural function in children? Observations in phenylketonuria. Prostaglandins Leukot Essent Fatty Acids 81:159–164PubMedCrossRef Koletzko B, Beblo S, Demmelmair H, Müller-Felber W, Hanebutt FL (2009) Does dietary DHA improve neural function in children? Observations in phenylketonuria. Prostaglandins Leukot Essent Fatty Acids 81:159–164PubMedCrossRef
go back to reference Kono K, Okano Y, Nakayama K, Hase Y, Minamikawa S, Ozawa N, Yokote N, Inoue Y (2005) Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 236:630–636PubMedCrossRef Kono K, Okano Y, Nakayama K, Hase Y, Minamikawa S, Ozawa N, Yokote N, Inoue Y (2005) Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 236:630–636PubMedCrossRef
go back to reference Korinthenberg R, Ullrich K, Füllenkemper F (1988) Evoked potentials and electroencephalography in adolescents with phenylketonuria. Neuropediatrics 19:175–178PubMedCrossRef Korinthenberg R, Ullrich K, Füllenkemper F (1988) Evoked potentials and electroencephalography in adolescents with phenylketonuria. Neuropediatrics 19:175–178PubMedCrossRef
go back to reference Lenassi E, Likar K, Stirn-Kranjc B, Brecelj J (2008) VEP maturation and visual acuity in infants and preschool childern. Doc Ophthalmol 117:111–120PubMedCrossRef Lenassi E, Likar K, Stirn-Kranjc B, Brecelj J (2008) VEP maturation and visual acuity in infants and preschool childern. Doc Ophthalmol 117:111–120PubMedCrossRef
go back to reference Leung S, Croft RJ, Guille V, Scholes K, O’Neill BV, Phan KL, Nathan PJ (2010) Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology 208:233–244PubMedCrossRef Leung S, Croft RJ, Guille V, Scholes K, O’Neill BV, Phan KL, Nathan PJ (2010) Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants. Psychopharmacology 208:233–244PubMedCrossRef
go back to reference Leuzzi V, Rinalduzzi S, Chiarotti F, Garzia P, Trasimeni G, Accornero N (1998) Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations. J Inherit Metab Dis 21:351–364PubMedCrossRef Leuzzi V, Rinalduzzi S, Chiarotti F, Garzia P, Trasimeni G, Accornero N (1998) Subclinical visual impairment in phenylketonuria. A neurophysiological study (VEP-P) with clinical, biochemical, and neuroradiological (MRI) correlations. J Inherit Metab Dis 21:351–364PubMedCrossRef
go back to reference Leuzzi V, Seri S, Cerquiglini A, Cl C, Ca C, Antonozzi I (2000) Derangement of the dopaminergic system in phenylketonuria: Study of the event-related potential (P300). J Inherit Metab Dis 23:317–320PubMedCrossRef Leuzzi V, Seri S, Cerquiglini A, Cl C, Ca C, Antonozzi I (2000) Derangement of the dopaminergic system in phenylketonuria: Study of the event-related potential (P300). J Inherit Metab Dis 23:317–320PubMedCrossRef
go back to reference Leuzzi V, Pansini M, Sechi E, Chiarotti F, Carducci C, Levi G, Antonozzi I (2004) Executive function impairment in early-treated PKU subjects with normal mental development. J Inherit Metab Dis 27:115–125PubMedCrossRef Leuzzi V, Pansini M, Sechi E, Chiarotti F, Carducci C, Levi G, Antonozzi I (2004) Executive function impairment in early-treated PKU subjects with normal mental development. J Inherit Metab Dis 27:115–125PubMedCrossRef
go back to reference Leuzzi V, Tosetti M, Montanaro D, Carducci C, Artiola C, Carducci C, Antonozzi I, Burroni M, Carnevale F, Chiarotti F, Popolizio P, Giannatempo GM, D’Alesio V, Scarabino T (2007) The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1 H MRS) study. J Inherit Metab Dis 30:209–216PubMedCrossRef Leuzzi V, Tosetti M, Montanaro D, Carducci C, Artiola C, Carducci C, Antonozzi I, Burroni M, Carnevale F, Chiarotti F, Popolizio P, Giannatempo GM, D’Alesio V, Scarabino T (2007) The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1 H MRS) study. J Inherit Metab Dis 30:209–216PubMedCrossRef
go back to reference Levitt P (2003) Structural and functional maturation of the developing primate brain. J Pediatr 143:S35–S45PubMedCrossRef Levitt P (2003) Structural and functional maturation of the developing primate brain. J Pediatr 143:S35–S45PubMedCrossRef
go back to reference Ludolph AC, Vetter U, Ullrich K (1996) Studies of multimodal evoked potentials in treated phenylketonuria: the pattern of vulnerability. Eur J Pediatr 15(suppl 1):S64–S68CrossRef Ludolph AC, Vetter U, Ullrich K (1996) Studies of multimodal evoked potentials in treated phenylketonuria: the pattern of vulnerability. Eur J Pediatr 15(suppl 1):S64–S68CrossRef
go back to reference Manara R, Burlina AP, Citton V, Ermani M, Vespignani F, Carollo C, Burlina AB (2009) Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria. Neuroradiology. doi:10.1007/s00234-009-0574-z PubMed Manara R, Burlina AP, Citton V, Ermani M, Vespignani F, Carollo C, Burlina AB (2009) Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria. Neuroradiology. doi:10.​1007/​s00234-009-0574-z PubMed
go back to reference Näätänen R (1990) The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behav Brain Sci 13:201–288CrossRef Näätänen R (1990) The role of attention in auditory information processing as revealed by event-related potentials and other brain measures of cognitive function. Behav Brain Sci 13:201–288CrossRef
go back to reference Näätänen R, Gaillard AWK, Mäntysalo S (1978) Early selective attention effect on evoked potential reinterpreted. Acta Psychol 42:313–329CrossRef Näätänen R, Gaillard AWK, Mäntysalo S (1978) Early selective attention effect on evoked potential reinterpreted. Acta Psychol 42:313–329CrossRef
go back to reference Näätänen R, Paavilainen P, Rinne T, Alho K (2007) The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin Neurophysiol 118:2544–2590PubMedCrossRef Näätänen R, Paavilainen P, Rinne T, Alho K (2007) The mismatch negativity (MMN) in basic research of central auditory processing: a review. Clin Neurophysiol 118:2544–2590PubMedCrossRef
go back to reference Odom JV, Bach M, Barber C, Brigell M, Marmor MF, Tormene AP, Holder GE (2004) Visual evoked potentials standard. Doc Ophthalmol 108:115–123PubMedCrossRef Odom JV, Bach M, Barber C, Brigell M, Marmor MF, Tormene AP, Holder GE (2004) Visual evoked potentials standard. Doc Ophthalmol 108:115–123PubMedCrossRef
go back to reference Perneger TV (1998) What’s wrong with Bonferroni adjustments. BMJ 316:1236–1238PubMed Perneger TV (1998) What’s wrong with Bonferroni adjustments. BMJ 316:1236–1238PubMed
go back to reference Pietz J, Schmidt E, Matthis P, Kobialka B, Kutscha A, De Sonneville LMJ (1993) EEGs in phenylketonuria. I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs aand cognitive function. Dev Med Child Neurol 35:54–64PubMedCrossRef Pietz J, Schmidt E, Matthis P, Kobialka B, Kutscha A, De Sonneville LMJ (1993) EEGs in phenylketonuria. I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs aand cognitive function. Dev Med Child Neurol 35:54–64PubMedCrossRef
go back to reference Scarabino T, Popolizio T, Tosetti M, Montanaro D, Giannatempo GM, Terlizzi R, Pollice S, Maiorana A, Maggialetti N, Carriero A, Leuzzi V, Salvolini U (2009) Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. Radiol Med 114:461–474PubMedCrossRef Scarabino T, Popolizio T, Tosetti M, Montanaro D, Giannatempo GM, Terlizzi R, Pollice S, Maiorana A, Maggialetti N, Carriero A, Leuzzi V, Salvolini U (2009) Phenylketonuria: white-matter changes assessed by 3.0-T magnetic resonance (MR) imaging, MR spectroscopy and MR diffusion. Radiol Med 114:461–474PubMedCrossRef
go back to reference Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, De Sonneville LMJ (1994) Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16:681–688PubMedCrossRef Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, De Sonneville LMJ (1994) Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16:681–688PubMedCrossRef
go back to reference Scriver CR, Eisensmith RC, Woo SLC (1995) The hyperphenylalaninemias, In: The Metabolic and Molecular Bases of Inherited Disease, 7th edn. McGraw-Hill, New York, pp 1015–1075 Scriver CR, Eisensmith RC, Woo SLC (1995) The hyperphenylalaninemias, In: The Metabolic and Molecular Bases of Inherited Disease, 7th edn. McGraw-Hill, New York, pp 1015–1075
go back to reference Stemerdink NBA, Van der Molen MW, Kalverboer AF, Van der Meere JJ, Huisman J, De Jong LWA, Slijper FME, Verkerk PH, Van Spronsen FJ (1999) Prefronal dysfunction in early and continuously treated phenylketonuria. Develop Neuropsychol 16:29–57CrossRef Stemerdink NBA, Van der Molen MW, Kalverboer AF, Van der Meere JJ, Huisman J, De Jong LWA, Slijper FME, Verkerk PH, Van Spronsen FJ (1999) Prefronal dysfunction in early and continuously treated phenylketonuria. Develop Neuropsychol 16:29–57CrossRef
go back to reference Stevens J (1996) Applied multivariate statistics for the social sciences. Lawrence Erlbaum, Mahwah, NJ Stevens J (1996) Applied multivariate statistics for the social sciences. Lawrence Erlbaum, Mahwah, NJ
go back to reference Tau GZ, Peterson BS (2010) Normal development of brain circuits. Neuropsychopharmacol Rev 35:147–168PubMedCrossRef Tau GZ, Peterson BS (2010) Normal development of brain circuits. Neuropsychopharmacol Rev 35:147–168PubMedCrossRef
go back to reference Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC, Kendall B, Lees AJ (1990) Neurological deterioration in young adults with phenylketonuria. Lancet 336:602–605PubMedCrossRef Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC, Kendall B, Lees AJ (1990) Neurological deterioration in young adults with phenylketonuria. Lancet 336:602–605PubMedCrossRef
go back to reference Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP (1993) Brain MRI changes in phenylketonuria. Associations with dietary status. Brain 116:811–821PubMedCrossRef Thompson AJ, Tillotson S, Smith I, Kendall B, Moore SG, Brenton DP (1993) Brain MRI changes in phenylketonuria. Associations with dietary status. Brain 116:811–821PubMedCrossRef
go back to reference Ullrich K, Weglage J, Oberwittler C, Pietsch M, Funders B, Eckhardstein HV (1996) Effect of L-Dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients. Eur J Pediatr 155(Suppl 1):S74–S77PubMedCrossRef Ullrich K, Weglage J, Oberwittler C, Pietsch M, Funders B, Eckhardstein HV (1996) Effect of L-Dopa on visual evoked potentials and neuropsychological tests in adult phenylketonuria patients. Eur J Pediatr 155(Suppl 1):S74–S77PubMedCrossRef
go back to reference Van Spronsen FJ, Hoeksma M, Reijngoud DJ (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef Van Spronsen FJ, Hoeksma M, Reijngoud DJ (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef
go back to reference VanZutphen KH, Packman W, Sporri L, Needham MC, Morgan C, Weisiger K, Packman S (2007) Executive functioning in children and adolescents with phenylketonuria. Clin Genet 72:13–18PubMedCrossRef VanZutphen KH, Packman W, Sporri L, Needham MC, Morgan C, Weisiger K, Packman S (2007) Executive functioning in children and adolescents with phenylketonuria. Clin Genet 72:13–18PubMedCrossRef
go back to reference Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58:1145–1156PubMedCrossRef Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58:1145–1156PubMedCrossRef
go back to reference Weglage J, Pietsch M, Funders B, Koch HG, Ullrich K (1996) Deficits in selective and sustained attention processes in early treated children with phenylketonuria: Result of impaired frontal lobe functions? Eur J Pediatr 155:200–2004PubMedCrossRef Weglage J, Pietsch M, Funders B, Koch HG, Ullrich K (1996) Deficits in selective and sustained attention processes in early treated children with phenylketonuria: Result of impaired frontal lobe functions? Eur J Pediatr 155:200–2004PubMedCrossRef
go back to reference Weglage J, Bick U, Schuierer G, Pietsch M, Sprinz A, Zab R, Ullrich K (1997) Progression of cerebral white matter abnormalities in early-treated patients with phenylketonuria during adolescence. Neuropediatrics 28:239–240PubMedCrossRef Weglage J, Bick U, Schuierer G, Pietsch M, Sprinz A, Zab R, Ullrich K (1997) Progression of cerebral white matter abnormalities in early-treated patients with phenylketonuria during adolescence. Neuropediatrics 28:239–240PubMedCrossRef
go back to reference Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev 61:1697–1713PubMedCrossRef Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early-treated phenylketonuria: specific executive function deficits. Child Dev 61:1697–1713PubMedCrossRef
go back to reference White D, Connor L, Nardos B, Shimony J, Archer R, Synder A, Moinuddin A, Grange D, Steiner R, McKinstry R (2009) Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated phenylketonuria: a diffusion tensor imaging study of the corpus callosum. Mol Genet Metab 99:S41–S46CrossRef White D, Connor L, Nardos B, Shimony J, Archer R, Synder A, Moinuddin A, Grange D, Steiner R, McKinstry R (2009) Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated phenylketonuria: a diffusion tensor imaging study of the corpus callosum. Mol Genet Metab 99:S41–S46CrossRef
go back to reference Winkler I (2007) Interpreting the mismatch negativity. J Psychophysiol 21:147–163CrossRef Winkler I (2007) Interpreting the mismatch negativity. J Psychophysiol 21:147–163CrossRef
Metadata
Title
Pre-attentive processing in children with early and continuously-treated PKU. Effects of concurrent Phe level and lifetime dietary control
Authors
Leo M. J. de Sonneville
Stephan C. J. Huijbregts
Robert Licht
Joseph A. Sergeant
Francjan J. van Spronsen
Publication date
01-08-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 4/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9321-9

Other articles of this Issue 4/2011

Journal of Inherited Metabolic Disease 4/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.